We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+38.21%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$108M
AUM Growth
–
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
87.56%
Top 10 Holdings %
Top 10 Hldgs %
39.31%
Holding
80
New
80
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Cytokinetics
CYTK
|
+$5.94M |
| 2 |
DRRX
DURECT Corp
DRRX
|
+$5.04M |
| 3 |
CLDR
Cloudera, Inc.
CLDR
|
+$4.58M |
| 4 |
Aviat Networks
AVNW
|
+$3.29M |
| 5 |
SFE
Safeguard Scientifics, Inc.
SFE
|
+$3.12M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 36.62% |
| 2 | Technology | 17.3% |
| 3 | Financials | 11.58% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Energy | 8.21% |
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM
CM Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for CM Management, which disclosed 80 positions worth $108M. Its ten largest holdings account for 39% of the portfolio.
Its largest position is Cytokinetics: 325,000 shares worth $6.75M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Technology and Financials.
- CM Management's largest Q4 2020 buy was Cytokinetics: 325,000 shares worth $6.75M.
- CM Management's ten largest holdings make up 39% of its $108M portfolio in Q4 2020.
- CM Management disclosed 80 positions in Q4 2020, its first 13F filing on record.
Based on CM Management's 13F filing for Q4 2020, filed 4 Feb 2021.